Search

Author/Creator Dutreix, Catherine

1. A phase 1/2, open‐label, dose‐escalation study of midostaurin in children with relapsed or refractory acute leukaemia. (11th September 2018)

Authors:
Zwaan, C. Michel; Söderhäll, Stefan; Brethon, Benoit; Luciani, Matteo; Rizzari, Carmelo; Stam, Ronald W.; Besse, Emmanuelle; Dutreix, Catherine; Fagioli, Franca; Ho, Phoenix A.; Dufour, Carlo; Pieters, Rob
Journal:
British journal of haematology
Issue:
Volume 185:Number 3(2019)
Page Start:
623
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. An Exposure‐Response Modeling Approach to Examine the Relationship Between Potency of CYP3A Inducer and Plasma 4β‐Hydroxycholesterol in Healthy Subjects. Issue 1 (10th June 2016)

Authors:
Jiang, Xuemin; Dutreix, Catherine; Jarugula, Venkateswar; Rebello, Sam; Won, Christina S.; Sun, Haiying
Journal:
Clinical pharmacology in drug development
Issue:
Volume 6:Issue 1(2017)
Page Start:
19
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Preclinical and Phase I Results of Decitabine in Combination with Midostaurin (PKC412) for Newly Diagnosed Elderly or Relapsed/Refractory Adult Patients with Acute Myeloid Leukemia. Issue 12 (24th June 2013)

Authors:
Williams, Casey B.; Kambhampati, Suman; Fiskus, Warren; Wick, Jo; Dutreix, Catherine; Ganguly, Siddartha; Aljitawi, Omar; Reyes, Ruben; Fleming, Allan; Abhyankar, Sunil; Bhalla, Kapil N.; McGuirk, Joseph P.
Journal:
Pharmacotherapy
Issue:
Volume 33:Issue 12(2013)
Page Start:
1341
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗